Navigation Links
Onconova Therapeutics Announces Presentation of Clinical and,Non-Clinical Results for Its Lead Compound ON 01910.Na at American,Association of Cancer Research Conference in Los Angeles

. Solomon, F. Chan, M. Zhao, S. Cosenza, M. Reddy, M. Rudek, P. Kulecza, E. P. Reddy and M. Hidalgo (abstract 5391).

About Onconova's Product-Pipeline

Onconova is developing several novel product candidates directed at critical kinase targets involved in the regulation of signal transduction, cell-cycle and DNA repair. These candidates are derived from the Company's proprietary library of new chemical entities and non-ATP competitive chemotypes. In addition to ON 01910.Na, Onconova is also developing Ex-RAD(TM), an injectable and oral radioprotectant, and inhibitors of JAK and Bcr-abl pathways.

About Onconova Therapeutics, Inc.

Onconova, based in Lawrenceville, NJ, discovers and develops novel therapeutic agents for cancer, radiation protection and hematological disorders. Currently, the Company is conducting clinical trials at major centers in the USA and abroad. The novel chemical library platform is permitting identification of non-ATP competitive kinase inhibitors directed at validated and novel targets, and a new immunoconjugate technology for arming monoclonal antibodies for cancer therapy. All of the Company's products and technologies are being developed internally.

For further information on Onconova Therapeutics, Inc., please visit http://www.onconova.com.

All trademarks are registered to their respective owners.

Contact

Investors
Onconova Therapeutics, Inc.
Dr. Ramesh Kumar
President and CEO
609-844-7735
or
Media
KMorrisPR
Kathryn Morris
845-635-9828
kathryn@kmorrispr.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:7/24/2008)...Newswire/ -- There are a record 301,new medicines ... a new,report released here today during a briefin...tal illnesses have on patients, their families,an...ly 60 million American,adults. The briefing, led b... America (PhRMA), featured Emmy Award-winning acto...
(Date:7/24/2008)...to take body temperature, for home,and clinical us...-- Kidz-Med, Inc.,(subsidiary of American Scientif...s distributor of the Thermofocus(R) 5-in-1 non-con...ts of a clinical study,conducted by the Second Chi...n, Italy, which proves that the Thermofocus(R) mea...
(Date:7/23/2008)...c Therapy to Treat the Disease -, WAYNE, N.J. and.../ --,Bayer HealthCare Pharmaceuticals and Onyx Pha...that The New England Journal of Medicine published...avar(R) (sorafenib),tablets decreased the absolute...sectable hepatocellular carcinoma (HCC), or liver ...
(Date:7/23/2008)...ewswire/ -- The following was,released by the U.S....g Member Smith, and Members of the Committee.,Than...e I appeared before this Committee almost six mont...the talented and dedicated professionals,at the Ju...have come to,appreciate that much more deeply thei...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 21694 1Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 21694 2Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 21694 3Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 21694 4Netsmarts Kevin Scalia Named Chair of the Software and Technology Vendors Association 5965 1Netsmarts Kevin Scalia Named Chair of the Software and Technology Vendors Association 5965 2Netsmarts Kevin Scalia Named Chair of the Software and Technology Vendors Association 5965 3Abnormal Sleep Patterns in Older Men Spell Trouble 21692 1Abnormal Sleep Patterns in Older Men Spell Trouble 21692 2Defeat Diabetes Foundation Announces Martial Arts Defeat Diabetes 28R 29 Community Action Project 28TM 29 21690 1Defeat Diabetes Foundation Announces Martial Arts Defeat Diabetes 28R 29 Community Action Project 28TM 29 21690 2
... Maintained for at Least 24 Weeks, According,to Re...May 15, 2007 /PRNewswire/ -- Researchers from Guy,...icine have,announced the results from the first ra...valuating botulinum toxin type A (BTX-A,BOTOX(R))...ty (IDO),in patients with symptoms of overactive b...
...S WIRE)--May 17, 2007 - Pro-Pharmaceuticals,Inc. ...carbohydrate,compounds today announced that Elieze...Development and Manufacturing will present,"Pharm...umors of,5-FU with an Admixture of a Galactomannan...developmental Biology and Medicine,(ISOBM) Confere...
Other Medicine Technology:First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 2First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 3First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 4Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 2Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 3Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 4Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 5
(Date:7/25/2008)... PLEASANTON, Calif., July 25 /PRNewswire-FirstCa...ld leader in device-based mechanical,circulatory s...ing hearts,today announced that it will report it...st six months of fiscal 2008 on Thursday, July 31....uss its financial,results and operating activities...
(Date:7/25/2008)... Atlanta, GA July 24, 2008 Being overweight or o...,s health but is also a public health issue that i... journal Health Services Research reveals that t...elderly people could place a significant financial...illions of dollars across the entire current Medic...
(Date:7/25/2008)... DALLAS, July 25 /PRNewswire/ -- BeaconEquity.co...ocks making news today., Investors can view all o...ttp://BeaconEquity.com/m , Today,s Trade Alerts i...,MiddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK ...aq: ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and,...
(Date:7/25/2008)...ataline is supporting the US Department of Defense...ion Golden Phoenix. Operation Golden Phoenix is a,...vent designed to assist, federal, state and local ... scenarios. Dataline is providing a vital, ad-ho...or medical use during the exercise., NORFOLK, Va....
Breaking Medicine News(10 mins):Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3
...otherapy brings about long lasting modifications i... responsible// for the mental fog and confusion in...y researchers at the University of California, Los... in the important region of the frontal cortex in ...
...r from over in Bihar with the detection of new cas...June-July immunisation drive this year//. Eight di...ered under the drive.Two new polio cases were dete...up in Arwal and Nawada districts. Patna district h...
...of daily physical exercise for their future good h...es at Glasgow University studied 545 children at 3... the children who had the recommended adult level ...three times a week, reported the online edition of...
...s, some cancer patients are experiencing unjust di...of the new legislation to protect their rights//. ...t from the end of last year has provided effective...evere illnesses like cancer, multiple sclerosis et...
Other Medicine News:Health News:Chemotherapy causes mental fog 2Health News:Injustice to cancer patients at work 2
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: